Ignite Creation Date:
2024-05-06 @ 7:39 PM
Last Modification Date:
2024-10-26 @ 3:11 PM
Study NCT ID:
NCT06088771
Status:
RECRUITING
Last Update Posted:
2024-03-15
First Post:
2023-10-06
Brief Title:
Neoadjuvant Dupilumab and Cemiplimab in Patients With Early-stage Resectable NSCLC
Sponsor:
Icahn School of Medicine at Mount Sinai
Organization:
Icahn School of Medicine at Mount Sinai
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-03-08
Start Date Type:
ACTUAL
Primary Completion Date:
2027-03
Primary Completion Date Type:
ESTIMATED
Completion Date:
2032-03
Completion Date Type:
ESTIMATED
First Submit Date:
2023-10-06
First Submit QC Date:
October 12 2023
Study First Post Date:
2023-10-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-13
Last Update Post Date:
2024-03-15
Last Update Post Date Type:
ACTUAL